PFIZER INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Public

Established: 1849-01-01

Employees: 88K

Market Cap: $163.3B

Website: http://www.pfizer.com

Clinical Trials

Tanezumab in Osteoarthritis Of The Hip

Phase 3

Completed

Conditions: Arthritis
Osteoarthritis
Osteoarthritis, Hip

Interventions: Biological: Placebo
Biological: tanezumab

First Posted Date: 2008-09-01

Last Posted Date: 2021-02-26

Lead Sponsor: Pfizer

Target Recruit Count: 627

Registration Number: NCT00744471

Locations: 🇺🇸
Providence Clinical Research, Burbank, California, United States
🇺🇸
Trinity Clinical Trials, Santa Ana, California, United States
🇺🇸
Stamford Therapeutics Consortium, Stamford, Connecticut, United States

and more 93 locations

A 6-Week Multicenter Trial Of Varenicline Tartrate For Cognitive Impairment In Subjects With Schizophrenia

Phase 2

Withdrawn

Conditions: Schizophrenia

Interventions: Drug: placebo
Drug: varenicline

First Posted Date: 2008-08-29

Last Posted Date: 2009-02-24

Lead Sponsor: Pfizer

Registration Number: NCT00743847

Study Evaluating the Impact of the 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Alaskan Native Children.

Phase 3

Completed

Conditions: Pneumococcal Disease
13-valent Pneumococcal Vaccine

Interventions: Biological: 13-valent Pneumococcal Conjugate Vaccine

First Posted Date: 2008-08-29

Last Posted Date: 2012-03-15

Lead Sponsor: Pfizer

Target Recruit Count: 373

Registration Number: NCT00743652

Locations: 🇺🇸
Pfizer Investigational Site, Upper Kalskag, Alaska, United States

Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults

Phase 4

Completed

Conditions: Pneumococcal Infections
13-valent Pneumococcal Vaccine
Pneumonia, Pneumococcal

First Posted Date: 2008-08-29

Last Posted Date: 2014-10-06

Lead Sponsor: Pfizer

Target Recruit Count: 84496

Registration Number: NCT00744263

Locations: 🇳🇱
Pfizer Investigational Site, Zwolle, Netherlands

A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb

Phase 1

Completed

Conditions: Osteoarthritis Thumbs

Interventions: Drug: Placebo
Drug: Oxycodone
Drug: Naproxen
Drug: Tramadol

First Posted Date: 2008-08-29

Last Posted Date: 2018-12-04

Lead Sponsor: Pfizer

Target Recruit Count: 36

Registration Number: NCT00743587

Locations: 🇧🇪
Pfizer Investigational Site, Bruxelles, Belgium

A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation

Phase 2

Withdrawn

Conditions: Smoking Cessation

Interventions: Drug: Varenicline Immediate Release 1 mg
Drug: Varenicline Controlled Release 2.4 mg
Drug: Placebo
Drug: Varenicline Controlled Release 1.2 mg
Drug: Varenicline Controlled Release 1.8 mg

First Posted Date: 2008-08-26

Last Posted Date: 2015-04-22

Lead Sponsor: Pfizer

Registration Number: NCT00741884

An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

Phase 2

Completed

Conditions: Interstitial Cystitis
Painful Bladder Syndrome

Interventions: Drug: placebo for PD 0299685
Drug: PD 0299685 at 15mg BID
Drug: PD 0299685 at 30mg BID

First Posted Date: 2008-08-22

Last Posted Date: 2011-03-28

Lead Sponsor: Pfizer

Target Recruit Count: 161

Registration Number: NCT00739739

Locations: 🇩🇪
Pfizer Investigational Site, Muenchen, Germany

Arthroscopic Surgical Outcome Study In Subjects With Rotator Cuff Tears

Completed

Conditions: Rotator Cuff
Arthroscopic Surgery

Interventions: Other: Observational study of the surgical outcome

First Posted Date: 2008-08-22

Last Posted Date: 2021-02-16

Lead Sponsor: Pfizer

Target Recruit Count: 162

Registration Number: NCT00739947

Locations: 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
🇺🇸
The Cleveland Clinic Foundation, Cleveland, Ohio, United States
🇺🇸
The Core Institute, Sun City, Arizona, United States

and more 26 locations

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Phase 2

Completed

Conditions: Candidiasis
Candidemia

Interventions: Drug: voriconazole (Vfend)

First Posted Date: 2008-08-22

Last Posted Date: 2011-01-28

Lead Sponsor: Pfizer

Target Recruit Count: 40

Registration Number: NCT00739934

Locations: 🇺🇸
Pfizer Investigational Site, Houston, Texas, United States

6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)

Phase 3

Withdrawn

Conditions: Generalized Anxiety Disorder

First Posted Date: 2008-08-20

Last Posted Date: 2012-12-03

Lead Sponsor: Pfizer

Registration Number: NCT00738738

Locations: 🇺🇸
Pfizer Investigational Site, Prairie Village, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy